3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Conditions
Multiple Sclerosis
2
Carcinoma in Situ
2
Sarcoma, Kaposi
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis, Chronic Progressive
1
HIV Infections
1
Acquired Immunodeficiency Syndrome
1
Interventions
Magnetic Resonance Imaging
2
Interferon beta-1b
2
Electrocardiography
2
Diphenhydramine
2
Acetaminophen
2
valrubicin
1
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
dodecyl maltoside
1
apaziquone
1
aldesleukin
1
Tomography, X-Ray Computed
1
Respiratory Function Tests
1
Proflavine
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nicotine Replacement Therapy
1
Meperidine
1
Mastectomy, Subcutaneous
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Imiquimod
1
Hydroxyzine
1
Histamine Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma in Situ
×
Interferon beta-1b
×
Clear all
NCT02486640
2023-07-24
BETAPREDICT
Bayer
Completed
162 enrolled
NCT03134573
2019-03-26
PROmyBETAapp
Bayer
Completed
96 enrolled